Venus Medtech still seeking cure for governance problems
The transcatheter maker’s shares were suspended last November, and it must still meet several conditions from the Hong Kong Stock Exchange before trading can resume Key Takeways: Venus Medtech disclosed…
2500.HK
Recent Articles
RELATED ARTICLES
-
Yibin Bank’s IPO spotlights challenges facing regional lenders
2596.HK
-
Country Garden’s debt restructure hinges on stabilizing property market
2007.HK
-
ZG Group set to forge Hong Kong’s second De-SPAC listing
2572.HK
-
No respite for RemeGen as problems and losses pile up
9995.HK 688331.SHG
-
Cash-hungry Mabwell seeks financial tonic from Hong Kong investors
688062.SHG
-
Seyond may get stuck in slow-moving SPAC lane to Hong Kong listing
7855.HK
-
Xiaocaiyuan sets the table for Hong Kong IPO. But is the timing right?
0999.HK
Discover hidden China stock gems in our weekly newsletter